Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRIL.TO | DRUG.CN | NGEN.VN | ||
| Company | Trillium Therapeutics Inc | Bright Minds Biosciences Inc | Nervgen Pharma Corp | ||
| Price Information | |||||
| Exchange | TSX | CNSX | TSX Venture | ||
| Open | 23.22 | 124.9100 | 5.840 | ||
| High | 23.45 | 131.8800 | 5.860 | ||
| Low | 23.22 | 121.8600 | 5.650 | ||
| Latest | 23.33 | 131.8800 | 5.800 | ||
| Change | +0.11 | +13.5400 | unch | ||
| % Change | +0.47% | +11.44% | unch | ||
| Volume | 60,423 | 3,600 | 58,516 | ||
| 20-Day Average Volume | 64,032 | 1,330 | 169,556 | ||
| Previous Close | 23.22 | 118.3400 | 5.800 | ||
| Industry | TSX Biotechnology | N/A | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 22.44 | 101.4845 | 5.372 | ||
| 20-Day Raw Stochastic | 55.19% | 100.00% | 75.85% | ||
| 20-Day Relative Strength | 72.62 | 74.03 | 63.16 | ||
| Weighted Alpha | -48.63 | +159.01 | +62.01 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 96% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.92% since 11/12/21 | +21.82% since 12/09/25 | -2.52% since 12/09/25 | ||
| Low | 22.24 on 11/17/21 | 110.3900 on 12/10/25 | 5.650 on 12/16/25 | ||
| High | 24.41 on 11/17/21 | 131.8800 on 12/16/25 | 6.250 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | +6.72% since 10/19/21 | +62.23% since 11/14/25 | +74.17% since 11/14/25 | ||
| Low | 21.73 on 10/20/21 | 80.4700 on 11/17/25 | 3.240 on 11/18/25 | ||
| High | 24.41 on 11/17/21 | 131.8800 on 12/16/25 | 6.580 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | +210.65% since 08/19/21 | +94.80% since 09/16/25 | +55.50% since 09/16/25 | ||
| Low | 7.48 on 08/20/21 | 64.6200 on 09/18/25 | 3.200 on 11/06/25 | ||
| High | 24.41 on 11/17/21 | 131.8800 on 12/16/25 | 6.580 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +123.90% since 05/19/21 | +239.63% since 06/13/25 | +63.38% since 06/16/25 | ||
| Low | 7.48 on 08/20/21 | 33.0100 on 06/30/25 | 2.710 on 08/20/25 | ||
| High | 24.41 on 11/17/21 | 131.8800 on 12/16/25 | 6.580 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,426,437 | 838,870 | 454,398 | ||
| Shares Outstanding, K | 104,995 | 7,089 | 78,344 | ||
| Annual Sales | 148,000 | 0 | 0 | ||
| Annual Net Income | -59,346,000 | -2,801,946 | -24,005,895 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -19,316,000 | -5,242,970 | -4,156,070 | ||
| 60-Month Beta | 1.40 | -3.90 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/12/21 | -0.74 on 08/15/25 | -0.06 on 11/24/25 | ||
| Latest Earnings Date | 11/15/21 | N/A | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||